BioSpace News Archive

BD, a leading global medical technology company, announced the U.S. launch of a Urine Culture Application for use with the BD Kiestra™ lab automation incubation and imaging system that can transform the way microbiology labs approach urine culture analysis.

Passage Bio, Inc., a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, announced that management will participate in two upcoming virtual investor conferences in June:

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of oral therapeutics for severe viral infections, announced that Jean-Pierre Sommadossi, Ph.D., Founder, Chairman and Chief Executive Officer of Atea will present a corporate overview at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 2:30 p.m. ET.

Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus -based gene therapies for the treatment of rare retinal diseases, announced the appointment of Janet C. Rae, RAC, as Senior Vice President of Global Regulatory and Quality.

Phase 3 GENESIS study in stem-cell mobilization (SCM) demonstrated highly statistically significant positive results across all primary and secondary endpoints

Valeo Pharma Inc., a Canadian pharmaceutical company, provided an outlook for its second quarter ended April 30th, projecting record revenues and margins.

Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, announced that David Hung, M.D., founder and chief executive officer of Nuvation Bio, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 9:00 a.m. ET.

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced that Andrew Robbins, Chief Executive Officer and President, will present at Jefferies Virtual Healthcare Conference on Thursday, June 3rd, from 11:30-11:55am ET.

Kim Jacques recognized for excellence in technology leadership in uncertain times

Solid Biosciences Inc., a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy, announced that Joel Schneider, PhD, Chief Operating Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 3:30 p.m. ET.